Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127888) titled 'Efficacy and Safety of Lacticaseibacillus paracasei for Pediatric Allergic Rhinitis: A Randomized Controlled Trial' on July 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Condition:
Moderate-to-Severe Allergic Rhinitis
Intervention:
Control group:Maltodextrin
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-11
Target Sample Size: Control group:60;Intervention group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.htm...